TrialBMJ open2015

Efficacy and Safety of Pergoveris in Assisted Reproductive Technology--ESPART: rationale and design of a randomised controlled trial in poor ovarian responders undergoing IVF/ICSI treatment.

P Humaidan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.